Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

recombinant interferon alfa-2a

A non-glycosylated recombinant human alpha interferon, subtype 2a, produced in the bacterium E. coli. Interferon alpha-2a binds to its specific cell-surface receptor, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune modulating effects.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:alpha 2 interferon
IFN alpha-2A
IFN-alpha 2
interferon alfa 2a
interferon alfa-2a
US brand name:Roferon A
Roferon-A
Foreign brand name:Laroferon
Roceron-A
Abbreviation:rHuIFN-a 2a
NSC code:367982
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search